Kane Biotech Completes Enrollment in U.S. Case Series Studies of its revyve(R) Antimicrobial Wound Gel and Spray
Kane Biotech Completes Enrollment in U.S. Case Series Studies of its revyve(R) Antimicrobial Wound Gel and Spray GlobeNewswire September 10, 2025 WINNIPEG, Manitoba, Sept. 10, 2025 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech” or “Kane”) today announces that it has enrolled 28 participants in its revyve(R) Antimicrobial Wound Gel and Spray U.S. Case […]